Nutritional Growth Solutions Ltd. (AU:NGS)
ASX:NGS
Want to see AU:NGS full AI Analyst Report?
Top Page
Nutritional Growth Solutions Ltd.
(Sydney:NGS)
Select Model
Select Model
Rating:42Neutral
Price Target:
AU$0.02
▼(-5.00% Downside)
Action:ReiteratedDate:03/24/26
The score is driven primarily by weak financial performance—shrinking revenue, sharply lower gross margin, persistent large losses, and ongoing cash burn—alongside elevated leverage despite equity turning positive. Technical indicators are broadly neutral and do not offset the fundamental risks, while valuation is constrained by negative earnings and no dividend support.
Positive Factors
Evidence‑based product focus
NGS's explicit emphasis on scientifically formulated, evidence‑based pediatric nutrition creates durable product differentiation. Clinical credibility supports long‑term trust with parents and healthcare professionals, aiding sustained adoption, higher retention and defensibility versus commodity alternatives.
Negative Factors
Shrinking revenue trend
Persistent top‑line decline, including a near 20% fall in 2025, signals structural demand or distribution issues. Sustained revenue shrinkage undermines scale economics, limits reinvestment capacity, and makes returning to profitability harder without clear product or market fixes.
Read all positive and negative factors
Positive Factors
Negative Factors
Evidence‑based product focus
NGS's explicit emphasis on scientifically formulated, evidence‑based pediatric nutrition creates durable product differentiation. Clinical credibility supports long‑term trust with parents and healthcare professionals, aiding sustained adoption, higher retention and defensibility versus commodity alternatives.
Read all positive factors
Nutritional Growth Solutions Ltd. (NGS) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$6.66M
Dividend YieldN/A
Average Volume (3M)283.41K
Price to Earnings (P/E)―
Beta (1Y)-8.12
Revenue Growth-32.83%
EPS Growth83.37%
CountryAU
Employees6
SectorConsumer Defensive
Sector Strength42
IndustryPackaged Foods
Share Statistics
EPS (TTM)-1.07
Shares Outstanding333,093,200
10 Day Avg. Volume24,410
30 Day Avg. Volume283,411
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.10
Price to Sales (P/S)0.01
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Nutritional Growth Solutions Ltd. Business Overview & Revenue Model
Company Description
Nutritional Growth Solutions Ltd. develops, produces, and sells pediatric protein supplements in the United States and internationally. It offers its products under the Horlicks, Healthy Height, and Pro Up brand names. The company was formerly kno...
How the Company Makes Money
Nutritional Growth Solutions Ltd. generates revenue primarily through the sale of its products, including nutritionally optimized drinks and supplements targeted at boosting the growth and development of children. Its products are sold via direct-...
Nutritional Growth Solutions Ltd. Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
30
Negative
Cash Flow
12
Very Negative
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.68M | 2.48M | 3.06M | 2.95M | 3.04M |
| Gross Profit | 263.89K | 811.00K | 842.00K | 1.44M | 1.36M |
| EBITDA | -1.66M | -2.45M | -3.01M | -4.32M | -4.71M |
| Net Income | -1.77M | -2.54M | -2.89M | -4.25M | -4.78M |
Balance Sheet | |||||
| Total Assets | 1.79M | 709.00K | 936.00K | 3.03M | 3.44M |
| Cash, Cash Equivalents and Short-Term Investments | 517.35K | 31.00K | 172.00K | 1.52M | 3.00M |
| Total Debt | 504.34K | 162.00K | 362.00K | 37.00K | 73.00K |
| Total Liabilities | 1.55M | 1.37M | 1.11M | 954.00K | 626.97K |
| Stockholders Equity | 240.16K | -658.00K | -177.00K | 2.08M | 2.81M |
Cash Flow | |||||
| Free Cash Flow | 0.00 | -1.93M | -2.35M | -6.98M | -3.74M |
| Operating Cash Flow | -1.25M | -1.93M | -2.35M | -6.97M | -3.69M |
| Investing Cash Flow | 0.00 | 0.00 | 0.00 | -4.00K | -63.06K |
| Financing Cash Flow | 1.77M | 1.78M | 998.00K | 2.21M | 3.42M |
Nutritional Growth Solutions Ltd. Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
50 Neutral | AU$21.95M | -2.06 | -41.69% | ― | 53.69% | 45.24% | |
44 Neutral | AU$1.94M | -0.12 | -168.40% | ― | 24.70% | -312.00% | |
42 Neutral | AU$6.66M | >-0.01 | 226.76% | ― | -32.83% | 83.37% | |
41 Neutral | AU$9.79M | -1.62 | -44.35% | ― | -32.09% | 34.85% | |
41 Neutral | AU$22.81M | -12.65 | -321.20% | ― | 2.96% | -866.67% |
* Consumer Defensive Sector Average
AU:NGS
Nutritional Growth Solutions Ltd.
0.02
>-0.01
-13.04%
AU:EVE
EVE Health Group Limited
0.03
>-0.01
-10.00%
AU:NUC
Nuchev Pty Ltd
0.14
-0.09
-40.00%
AU:HCT
Holista Colltech Limited
0.07
0.03
77.50%
AU:TFL
TasFoods Limited
0.01
0.00
0.00%
Nutritional Growth Solutions Ltd. Corporate Events
Nutritional Growth Solutions Resets Cost Base and Balance Sheet as Operations Stabilise
Apr 20, 2026
Nutritional Growth Solutions reported a pivotal March quarter marked by a management overhaul, a structural cost reset and the full repayment of all legacy debt, leaving the company debt-free with cash of US$710,000. The cost program removed about...
Nutritional Growth Solutions Updates Australian Registered Office Address
Apr 20, 2026
Nutritional Growth Solutions has updated its registered office address in Australia to Suite 301, 2 Nexus Court, Mulgrave, Victoria, while keeping all other contact details unchanged. The administrative move signals continued structuring of its Au...
Nutritional Growth Solutions Reshapes Leadership as It Explores Corporate Options
Apr 15, 2026
Nutritional Growth Solutions, a U.S.-based health and wellness company, develops and sells clinically tested nutritional supplements specifically formulated for children aged three to twelve. Drawing on two decades of pediatric nutrition research,...
Nutritional Growth Solutions Chair Updates Shareholding Disclosure After Late Appendix 3Y Filing
Apr 10, 2026
Nutritional Growth Solutions has disclosed that its newly appointed Chair, Andrew Grover, has lodged a Change of Director’s Interest Notice later than the timeframe set out in ASX Listing Rule 3.19A, after choosing to include shares exclusiv...
Nutritional Growth Solutions Names Andrew Grover as Chair and Files Annual Report
Mar 24, 2026
Nutritional Growth Solutions Limited has appointed director and interim CEO Andrew Grover as Chair effective 23 March 2026, with former Chair Guy Khavia remaining on the board as a non-executive director. The change in leadership coincides with th...
Nutritional Growth Solutions Files Updated ASX Corporate Governance Statement
Mar 24, 2026
Nutritional Growth Solutions Ltd. has lodged its corporate governance statement for the year ended 31 December 2025 with the ASX, confirming that the statement is current as of 24 March 2026 and approved by the board. The company has also submitte...
Nutritional Growth Solutions details governance practices and plans for diversity framework
Mar 24, 2026
Nutritional Growth Solutions Ltd. has released its 2025 Corporate Governance Statement outlining its level of alignment with the ASX Corporate Governance Council’s Principles and Recommendations. The company discloses that it complies with s...
Nutritional Growth Solutions Names New ASX Liaison to Bolster Governance
Mar 1, 2026
Nutritional Growth Solutions has appointed Adam Gallagher as its new local agent and the responsible person for communications with the ASX, effective immediately. Gallagher, an experienced company secretary and governance professional who support...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.